Exemestane
9 NDCs across 9 manufacturers|8 Generic,1 Brand
Exemestane is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 21, 1999, and the first generic was approved Apr 1, 2011. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $33 million on Exemestane across 213,000 claims for 55,000 beneficiaries.
Exemestane is available as 9 NDCs from 9 manufacturers (8 generic, 1 brand), with NADAC prices from $0.72 to $38.98 per EA — the most expensive product costs about 54× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
8G / 1B
Manufacturers
9
competing in market
Price Spread
$0.72 – $38.98
per EA
7d Activity
avg +4.5% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
9 manufacturers producing EXEMESTANE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AROMASIN 25 MG TABLET | $38.9792 per EA | — |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
EXEMESTANE 25 MG TABLET | $0.7177 per EA | +4.46% |
Frequently Asked Questions
What is Exemestane used to treat?
Exemestane is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
When did Exemestane become available as a generic?
FDA approved the first generic Exemestane (ANDA) on Apr 1, 2011. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Exemestane?
In 2024, Medicare Part D spent $33 million on Exemestane across 213,000 claims for 55,000 beneficiaries.
How many Exemestane products are on the market?
The Exemestane drug market contains 9 NDCs from 9 manufacturers — 8 generic and 1 brand product.
What is the price range for Exemestane?
NADAC reference prices for Exemestane range from $0.7177 to $38.9792 per EA — the most expensive product costs about 54× the cheapest.
Is generic Exemestane cheaper than brand?
The average generic NADAC for Exemestane is $0.7177 per EA, versus $38.9792 for brand-labeled products — brand versions average about 54× the generic price.
Which manufacturers make Exemestane?
9 manufacturers list Exemestane in NADAC. Ranked by number of NDCs, the largest are Pharmacia & Upjohn Company LLC (1), Breckenridge Pharmaceutical Inc. (1), Aurobindo Pharma Limited (1), Mylan Pharmaceuticals Inc. (1), Upsher-Smith Laboratories LLC (1).
How has the price of Exemestane changed recently?
Over the past 7 days, 8 Exemestane NDCs rose and 0 fell, with a market-wide average change of +4.5%.